GSK plc

GSK plc EPS

The Earnings per Share (EPS) of GSK plc (GSK.L) as of Oct 19, 2026 is 1.40 GBP. In the previous year, Earnings per Share (EPS) was 0.62 GBP — a change of 125.19% (higher).

EPS

1.40GBP

YoY

125.19%

Last updated:

Earnings per Share (EPS) of GSK plc is 2025 1.40 GBP. Earnings per Share (EPS) of GSK plc was 2024 0.62 GBP. It decreases by 125.19% higher compared to the previous year.

The GSK plc EPS history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EPS
Date
EPS
Jan 1, 2024
0.62 GBP
Jan 1, 2025
1.40 GBP
Jan 1, 2026 (e)
1.78 GBP
Jan 1, 2027 (e)
1.89 GBP
Jan 1, 2028 (e)
1.99 GBP
Jan 1, 2029 (e)
2.15 GBP
Jan 1, 2030 (e)
2.19 GBP
Jan 1, 2031 (e)
1.97 GBP
The GSK plc EPS history
YEAREPSYoY
est1.97GBP-10.13%
est2.19GBP+2.23%
est2.15GBP+7.75%
est1.99GBP+5.16%
est1.89GBP+6.20%
est1.78GBP+27.53%
1.40GBP+125.19%
0.62GBP-48.09%
1.20GBP-67.26%
3.66GBP+170.59%
1.35GBP-5.21%
1.43GBP+23.28%
1.16GBP+27.09%
0.91GBP+132.36%
0.39GBP+68.81%
0.23GBP-89.34%
2.18GBP+206.98%
0.71GBP-49.08%
1.39GBP+21.62%
1.14GBP-12.52%
1.31GBP+225.81%
0.40GBP-70.55%
1.36GBP+21.12%
1.13GBP-4.12%
1.17GBP-2.40%
1.20GBP—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

GSK plc Stock analysis

What does GSK plc do? GSK plc, listed on the London Stock Exchange under the ticker GSK.L, is a pharmaceutical company headquartered in Brentford, United Kingdom. The company, which has been publicly traded since May 22, 1972, operates within the healthcare sector, specifically in the pharmaceuticals industry. GSK employs 94,066 full-time staff, focusing on the research, development, and manufacturing of pharmaceutical medicines, vaccines, and consumer healthcare products. The company's operations are structured around two primary segments: Pharmaceuticals and Vaccines. In the Pharmaceuticals segment, GSK develops and markets medicines for a variety of conditions, including respiratory diseases, HIV and infectious diseases, immuno-inflammation, oncology, and rare diseases. The Vaccines segment provides immunization solutions for all age groups, from infants to the elderly, including pediatric, adolescent, adult, and travel vaccines. GSK's portfolio includes prescription medicines and vaccines, with a particular emphasis on respiratory and HIV-related treatments. The company's business strategy encompasses both innovative therapeutic areas and established product lines, supporting its global presence in healthcare. GSK's official website is www.gsk.com, offering further information about its products and initiatives. GSK plc is one of the most popular companies on Eulerpool.

Frequently Asked Questions about GSK plc stock

Earnings per Share (EPS) of GSK plc is 1.40 GBP in 2025.

Earnings per Share (EPS) of GSK plc changed from 0.62 GBP to 1.40 GBP, representing a 125.19% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Earnings per Share (EPS) GSK plc since 2006 – with annual values, charts, and detailed analysis.

Earnings per Share measures the portion of a company's profit allocated to each outstanding share. It is a key metric for assessing a company's profitability on a per-share basis.

EPS = Net Income / Shares Outstanding

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — GSK plc

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — GSK plc